| Dataset | Tahoe Therapeutics Tahoe 100M Perturbation Atlas |
| Category | transcriptomics |
| Type | cell type |
| Description | Adenine perturbation in Hs 766T cell line (Tahoe Therapeutics) |
| Similar Terms | |
| Downloads & Tools |
200 genes differentially expressed following the Adenine_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| MTSS1 | metastasis suppressor 1 | 0.148078 |
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.104977 |
| LMO7 | LIM domain 7 | 0.0883455 |
| PODXL | podocalyxin-like | 0.0765803 |
| FTH1 | ferritin, heavy polypeptide 1 | 0.0716047 |
| PALM2AKAP2 | PALM2 and AKAP2 fusion | 0.0715633 |
| PLEC | plectin | 0.0663233 |
| SLC35F3 | solute carrier family 35, member F3 | 0.0607953 |
| TRIO | trio Rho guanine nucleotide exchange factor | 0.0580841 |
| INTS6 | integrator complex subunit 6 | 0.0572888 |
| TGM2 | transglutaminase 2 | 0.055166 |
| KCNK1 | potassium channel, two pore domain subfamily K, member 1 | 0.0538051 |
| KCNMA1 | potassium channel, calcium activated large conductance subfamily M alpha, member 1 | 0.0536653 |
| SQSTM1 | sequestosome 1 | 0.0528716 |
| ST3GAL6 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | 0.0497458 |
| RAI14 | retinoic acid induced 14 | 0.0468683 |
| LAMC2 | laminin, gamma 2 | 0.0455126 |
| PDLIM5 | PDZ and LIM domain 5 | 0.0446706 |
| NAV2 | neuron navigator 2 | 0.0391229 |
| ZMYND8 | zinc finger, MYND-type containing 8 | 0.0385676 |
| SULF2 | sulfatase 2 | 0.0381863 |
| MACF1 | microtubule-actin crosslinking factor 1 | 0.0369857 |
| MSN | moesin | 0.0368538 |
| PCDH1 | protocadherin 1 | 0.0358686 |
| MEF2A | myocyte enhancer factor 2A | 0.0352567 |
| PLS3 | plastin 3 | 0.0347768 |
| HERC4 | HECT and RLD domain containing E3 ubiquitin protein ligase 4 | 0.0344198 |
| PTK2 | protein tyrosine kinase 2 | 0.0336282 |
| SLC5A3 | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | 0.0333821 |
| HM13 | histocompatibility (minor) 13 | 0.0317479 |
| HLA-E | major histocompatibility complex, class I, E | 0.0317311 |
| ALCAM | activated leukocyte cell adhesion molecule | 0.0314208 |
| DDX60L | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like | 0.0291307 |
| BCAR3 | breast cancer anti-estrogen resistance 3 | 0.0281659 |
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.0279768 |
| EXT1 | exostosin glycosyltransferase 1 | 0.027071 |
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.0268552 |
| AHNAK | AHNAK nucleoprotein | 0.026772 |
| MPRIP | myosin phosphatase Rho interacting protein | 0.0259304 |
| ZMIZ1 | zinc finger, MIZ-type containing 1 | 0.0253847 |
| SMYD3 | SET and MYND domain containing 3 | 0.0251084 |
| ANKRD11 | ankyrin repeat domain 11 | 0.0250992 |
| ANO1 | anoctamin 1, calcium activated chloride channel | 0.0248222 |
| JMJD1C | jumonji domain containing 1C | 0.0247388 |
| CDK6 | cyclin-dependent kinase 6 | 0.0243942 |
| DOK5 | docking protein 5 | 0.0242582 |
| CEMIP | cell migration inducing protein, hyaluronan binding | 0.02422 |
| MYH9 | myosin, heavy chain 9, non-muscle | 0.0239324 |
| DENND1A | DENN/MADD domain containing 1A | 0.0231396 |
| EIF3A | eukaryotic translation initiation factor 3, subunit A | 0.0230176 |
| CDKN2A | cyclin-dependent kinase inhibitor 2A | 0.0226539 |
| NCOR2 | nuclear receptor corepressor 2 | 0.0224891 |
| EHBP1L1 | EH domain binding protein 1-like 1 | 0.0223596 |
| EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 0.0221259 |
| HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 0.0220973 |
| VEGFA | vascular endothelial growth factor A | 0.0218651 |
| EGFR | epidermal growth factor receptor | 0.0218345 |
| CLIC4 | chloride intracellular channel 4 | 0.0217352 |
| HDAC9 | histone deacetylase 9 | 0.0215643 |
| SPIRE1 | spire-type actin nucleation factor 1 | 0.0215218 |
| AOPEP | aminopeptidase O (putative) | 0.0214537 |
| N4BP2L2 | NEDD4 binding protein 2-like 2 | 0.0213737 |
| GBE1 | glucan (1,4-alpha-), branching enzyme 1 | 0.0213402 |
| EFNA5 | ephrin-A5 | 0.0213313 |
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | 0.0211858 |
| RALY | RALY heterogeneous nuclear ribonucleoprotein | 0.0206628 |
| THSD4 | thrombospondin, type I, domain containing 4 | 0.0204946 |
| TRAPPC9 | trafficking protein particle complex 9 | 0.0204239 |
| ABI3BP | ABI family, member 3 (NESH) binding protein | 0.0203294 |
| HSPG2 | heparan sulfate proteoglycan 2 | 0.0202216 |
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.0200993 |
| KIAA1217 | KIAA1217 | 0.0200942 |
| WDFY2 | WD repeat and FYVE domain containing 2 | 0.0200922 |
| EPB41L1 | erythrocyte membrane protein band 4.1-like 1 | 0.0200516 |
| SMG1 | SMG1 phosphatidylinositol 3-kinase-related kinase | 0.0199873 |
| ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 0.0199234 |
| IARS1 | isoleucyl-tRNA synthetase 1 | 0.0198659 |
| HMGA2 | high mobility group AT-hook 2 | 0.0198391 |
| LAMA5 | laminin, alpha 5 | 0.0198196 |
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.0196562 |
| UTRN | utrophin | 0.0194026 |
| ASPH | aspartate beta-hydroxylase | 0.0192926 |
| RNF217 | ring finger protein 217 | 0.0189747 |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.0189398 |
| CMIP | c-Maf inducing protein | 0.0189153 |
| EXOC4 | exocyst complex component 4 | 0.0188293 |
| CORO2A | coronin, actin binding protein, 2A | 0.018741 |
| PSD3 | pleckstrin and Sec7 domain containing 3 | 0.0187373 |
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.0186302 |
| CDR2 | cerebellar degeneration-related protein 2, 62kDa | 0.0185825 |
| RAD51B | RAD51 paralog B | 0.0184839 |
| NIBAN2 | niban apoptosis regulator 2 | 0.0184297 |
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.0183128 |
| PLTP | phospholipid transfer protein | 0.0182887 |
| KDM4C | lysine (K)-specific demethylase 4C | 0.0182696 |
| RPS6KA3 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | 0.0182674 |
| ATP9A | ATPase, class II, type 9A | 0.0182639 |
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.0182492 |
| BLCAP | bladder cancer associated protein | 0.0182302 |
| GRB10 | growth factor receptor-bound protein 10 | 0.0182171 |
| Symbol | Name | Standardized Value |
|---|---|---|
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | -0.114457 |
| TMSB10 | thymosin beta 10 | -0.109795 |
| MT2A | metallothionein 2A | -0.085126 |
| RPS21 | ribosomal protein S21 | -0.059458 |
| ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | -0.0547643 |
| CLU | clusterin | -0.0546979 |
| TMSB4X | thymosin beta 4, X-linked | -0.0507238 |
| GPRC5A | G protein-coupled receptor, class C, group 5, member A | -0.0480219 |
| B2M | beta-2-microglobulin | -0.04468 |
| YBX3 | Y box binding protein 3 | -0.0434667 |
| ERC2 | ELKS/RAB6-interacting/CAST family member 2 | -0.0427504 |
| LMNA | lamin A/C | -0.042356 |
| VCL | vinculin | -0.0421261 |
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | -0.0412335 |
| GNAS | GNAS complex locus | -0.0410695 |
| RPS19 | ribosomal protein S19 | -0.040926 |
| S100A10 | S100 calcium binding protein A10 | -0.0390269 |
| PTMA | prothymosin, alpha | -0.0385023 |
| HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | -0.0375372 |
| IFI16 | interferon, gamma-inducible protein 16 | -0.0367076 |
| LOC112694756 | uncharaterized LOC112694756 | -0.0365951 |
| TOP2A | topoisomerase (DNA) II alpha 170kDa | -0.0350082 |
| ANLN | anillin, actin binding protein | -0.0335272 |
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | -0.0332749 |
| NAMPT | nicotinamide phosphoribosyltransferase | -0.0328001 |
| IFITM3 | interferon induced transmembrane protein 3 | -0.0326796 |
| NDRG1 | N-myc downstream regulated 1 | -0.0324846 |
| ALDH3A1 | aldehyde dehydrogenase 3 family, member A1 | -0.0323092 |
| RPL8 | ribosomal protein L8 | -0.0314669 |
| RPLP2 | ribosomal protein, large, P2 | -0.0314327 |
| MT1X | metallothionein 1X | -0.0311921 |
| S100A4 | S100 calcium binding protein A4 | -0.0310544 |
| IFI6 | interferon, alpha-inducible protein 6 | -0.030972 |
| RPLP1 | ribosomal protein, large, P1 | -0.0304993 |
| SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | -0.0299433 |
| KRT17 | keratin 17, type I | -0.0298764 |
| RPL32 | ribosomal protein L32 | -0.0290245 |
| IER3 | immediate early response 3 | -0.0287994 |
| S100A6 | S100 calcium binding protein A6 | -0.0282884 |
| H1-0 | H1.0 linker histone | -0.0272507 |
| ENO1 | enolase 1, (alpha) | -0.0271284 |
| RPL12 | ribosomal protein L12 | -0.0267728 |
| IFITM1 | interferon induced transmembrane protein 1 | -0.0267117 |
| CUL4B | cullin 4B | -0.0264702 |
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | -0.0263242 |
| IRF2BP2 | interferon regulatory factor 2 binding protein 2 | -0.0258533 |
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | -0.0249722 |
| IGFBP4 | insulin-like growth factor binding protein 4 | -0.0249586 |
| RPS6 | ribosomal protein S6 | -0.0249306 |
| TAGLN2 | transgelin 2 | -0.0248548 |
| KMT2E | lysine (K)-specific methyltransferase 2E | -0.0247434 |
| SF3B2 | splicing factor 3b, subunit 2, 145kDa | -0.0243253 |
| SH3BGRL3 | SH3 domain binding glutamate-rich protein like 3 | -0.0241614 |
| RPL23 | ribosomal protein L23 | -0.0241495 |
| IL1RAPL1 | interleukin 1 receptor accessory protein-like 1 | -0.024114 |
| PFN1 | profilin 1 | -0.0239495 |
| PGK1 | phosphoglycerate kinase 1 | -0.0236494 |
| ATP5F1E | ATP synthase F1 subunit epsilon | -0.0234661 |
| MARCKS | myristoylated alanine-rich protein kinase C substrate | -0.0233023 |
| TM4SF1 | transmembrane 4 L six family member 1 | -0.0231715 |
| S100A9 | S100 calcium binding protein A9 | -0.0228277 |
| ITGA6 | integrin, alpha 6 | -0.022485 |
| PRELID2 | PRELI domain containing 2 | -0.0223984 |
| ARPC1B | actin related protein 2/3 complex, subunit 1B, 41kDa | -0.0223933 |
| LMAN1 | lectin, mannose-binding, 1 | -0.0222387 |
| SYPL1 | synaptophysin-like 1 | -0.0220165 |
| CTNND1 | catenin (cadherin-associated protein), delta 1 | -0.0217846 |
| EIF4A1 | eukaryotic translation initiation factor 4A1 | -0.0217161 |
| PLAT | plasminogen activator, tissue | -0.0216453 |
| RPL36A | ribosomal protein L36a | -0.0215428 |
| RPL35 | ribosomal protein L35 | -0.021354 |
| WASF2 | WAS protein family, member 2 | -0.0212325 |
| SAMD9 | sterile alpha motif domain containing 9 | -0.021141 |
| SLC38A2 | solute carrier family 38, member 2 | -0.0210639 |
| MORF4L2 | mortality factor 4 like 2 | -0.020702 |
| DLG1 | discs, large homolog 1 (Drosophila) | -0.0205321 |
| TPT1 | tumor protein, translationally-controlled 1 | -0.020457 |
| FSCN1 | fascin actin-bundling protein 1 | -0.0204335 |
| OGA | O-GlcNAcase | -0.020314 |
| CNRIP1 | cannabinoid receptor interacting protein 1 | -0.0201884 |
| UQCRB | ubiquinol-cytochrome c reductase binding protein | -0.0201827 |
| ZNFX1 | zinc finger, NFX1-type containing 1 | -0.0201726 |
| COX4I1 | cytochrome c oxidase subunit IV isoform 1 | -0.0197561 |
| ITM2B | integral membrane protein 2B | -0.0192122 |
| RSF1 | remodeling and spacing factor 1 | -0.0190235 |
| TPX2 | TPX2, microtubule-associated | -0.0189722 |
| RPS4X | ribosomal protein S4, X-linked | -0.0188261 |
| IFIH1 | interferon induced with helicase C domain 1 | -0.0187404 |
| RPL36 | ribosomal protein L36 | -0.0187358 |
| MYL12B | myosin, light chain 12B, regulatory | -0.0187035 |
| PLAC8 | placenta-specific 8 | -0.0183874 |
| DSTN | destrin (actin depolymerizing factor) | -0.0183452 |
| ZC3HAV1 | zinc finger CCCH-type, antiviral 1 | -0.0182275 |
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta | -0.0182021 |
| RB1CC1 | RB1-inducible coiled-coil 1 | -0.0181755 |
| LIFR | leukemia inhibitory factor receptor alpha | -0.0181489 |
| HSP90B1 | heat shock protein 90kDa beta (Grp94), member 1 | -0.018141 |
| RPLP0 | ribosomal protein, large, P0 | -0.0180936 |
| IGF2 | insulin-like growth factor 2 | -0.0180926 |
| MIDN | midnolin | -0.0180231 |
